NCT04454892Recruiting
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
A Study on the Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS) in Mainland China
Source: ClinicalTrials.gov · Last updated 2 Jul 2020 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1. Describe the distribution of ALS in mainland China, to explore the differences in the number of ALS in different times, regions and populations in order to further explore the causes affecting the distribution of ALS; 2. To investigate the cause of ALS in mainland China in the crowd disease development process and the corresponding characteristics change ; 3. To explore the effect of prognosis of ALS;
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 29 Jun 2020
- Start date
- 1 Nov 2019
- Primary completion date
- 1 Dec 2030
- Lead sponsor
- Peking University Third Hospital
- Diseases
- ALS (motor neurone disease)
- NCT number
- NCT04454892
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 1 Nov 2019 to the primary completion date, 1 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Decline to follow-up.
Who the study is looking for
- \- Patients were diagnosed with ALS recruited from all participant clinical centers.The diagnosis of ALS was made using the revised El Escorial criteria for definite, probable, lab-supported, and possible.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University Third Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.